Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578

Lactococcus garvieae BCC 43578 produces a novel class II bacteriocin, garvieacin Q (GarQ), 70 amino acids in length and containing a 20-amino-acid N-terminal leader peptide. It is cleaved at the Gly-Gly site to generate the mature GarQ (5,339 Da), which is especially inhibitory against Listeria monocytogenes ATCC 19115 and other L. garvieae strains.     

A Novel Anti-cancer Peptide Extracted from Gynura pseudochina Rhizome: Cytotoxicity Dependent on Disulfide Bond Formation

International Journal of Peptide Research and Therapeutics - As current anticancer drugs have limitations, researchers have sought novel anti-cancer agents with high specificity and fewer side...     

Utilization of Whole-Cell MALDI-TOF Mass Spectrometry to Differentiate Burkholderia pseudomallei Wild-Type and Constructed Mutants

Whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (whole-cell MALDI-TOF MS) has been widely adopted as a useful technology in the identification and typing of microorganisms. This study employed the whole-cell MALDI-TOF MS to identify and differentiate wild-type and mutants containing constructed single gene mutations of Burkholderia pseudomallei, a pathogenic bacterium causing melioidosis disease in both humans and animals. Candidate biomarkers for the B. pseudomallei mutants, including rpoS, ppk, and bpsI isolates, were determined. Taxon-specific and clinical isolate-specific biomarkers of B. pseudomallei were consistently found and conserved across all average mass spectra. Cluster analysis of MALDI spectra of all isolates exhibited separate distribution. A total of twelve potential mass peaks discriminating between wild-type and mutant isolates were identified using ClinProTools analysis. Two peaks (m/z 2721 and 2748 Da) were specific for the rpoS isolate, three (m/z 3150, 3378, and 7994 Da) for ppk, and seven (m/z 3420, 3520, 3587, 3688, 4623, 4708, and 5450 Da) for bpsI. Our findings demonstrated that the rapid, accurate, and reproducible mass profiling technology could have new implications in laboratory-based rapid differentiation of extensive libraries of genetically altered bacteria.     

Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells

There is considerable current interest in developing antimicrobial and anticancer agents with a new mode of action. The antimicrobial peptides are regarded as a potential solution for treating cancer cells. The antimicrobial effect of 6 synthetic peptides against 7 bacterial species was evaluated. The result showed that IsCT, BmKn2 and BMAP-28 exhibited broad range of action against Bacillus subtilis ATCC 6633, Staphylococcus aureus ATCC 6538, methicillin resistant S. aureus DMST 20651, Staphylococcus epidermidis ATCC 12228, Acinetobacter baumanii ATCC 19066, Escherichia coli ATCC 25922 and Salmonella typhi DMST 562 at minimal inhibitory concentrations (MIC) of 2.97–24.28 μM. Neither AMP induced significant hemolysis, or showed cytotoxic on dental pulp stem cells and smooth muscle cells at their MICs. In addition, BmKn2 inhibited growth of human oral squamous carcinoma HSC4 cells and human colon cancer SW620 cells with IC₅₀ of 17.26 and 40 µM, respectively. Taken together, BmKn2 peptide from scorpion venom may offer a novel therapeutic strategy for development of cationic antimicrobial and anticancer peptides as potential new therapeutic agents.     

Culture degeneration in conidia of Beauveria bassiana and virulence determinants by proteomics

The quality of Beauveria bassiana conidia directly affects the virulence against insects. In this study, continuous subculturing of B. bassiana on both rice grains and potato dextrose agar (PDA) resulted in 55 and 49 % conidial yield reduction after 12 passages and 68 and 60 % virulence reduction after 20 and 12 passages at four d post-inoculation, respectively. The passage through Tenebrio molitor and Spodoptera exigua restored the virulence of rice and PDA subcultures, respectively. To explore the molecular mechanisms underlying the conidial quality and the decline of virulence after multiple subculturing, we investigated the conidial proteomic changes. Successive subculturing markedly increased the protein levels in oxidative stress response, autophagy, amino acid homeostasis, and apoptosis, but decreased the protein levels in DNA repair, ribosome biogenesis, energy metabolism, and virulence. The nitro blue tetrazolium assay verified that the late subculture's colony and conidia had a higher oxidative stress level than the early subculture. A 2A-type protein phosphatase and a Pleckstrin homology domain protein Slm1, effector proteins of the target of rapamycin (TOR) complex 1 and 2, respectively, were dramatically increased in the late subculture. These results suggest that TOR signalling might be associated with ageing in B. bassiana late subculture, in turn affecting its physiological characteristics and virulence.     

BAMP-28 Antimicrobial Peptide Against Different MALDI Biotype of Carbapenam Resistant Enterobacteriaceae

Worldwide emergence of Carbapenam resistance in Enterobacteriaceae (CRE) are increasing globally and becoming a severe public health issue. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. Due to their unique mode of action, antimicrobial peptides are novel alternatives to traditional antibiotics for tackling the issue of bacterial multidrug resistance. An easy, rapid and accurate detection of 72 clinically CRE isolates using a MALDI–TOF MS was additionally developed. The CRE isolates belonging to 33 Carbapenam-resistant Klebsiella pneumoniae, 17 Carbapenam-resistant Escherichia coli, 16 Carbapenam-resistant Enterobacter cloacae and 6 Carbapenam-resistant Citrobacter freundii carrying blaNDM-1 were definitely discriminated from reference genotype strain by MALDI–TOF MS. This rapid, accurate, and reproducible peptide signature profiling technology could have new implications in laboratory-based high-throughput differentiation of extensive libraries of Carbapenam resistant Enterobacteriaceae. Antibacterial activity of 9 short novel peptides against these CRE isolates were investigated. Although neither synthetic peptides induced significant hemolysis, or showed cytotoxic on Vero cell, only BAMP-28 peptide inhibited growth of K. pneumoniae, E. coli, C. freundii and E. cloacae with MIC₅₀ of 18–40, 20–40, 16–25 and 18–36 µM, respectively. In conclusion, MALDI–TOF MS can be used to screen for Carbapenam resistance in K. pneumoniae, E. coli, E. cloacae and C. freundii. Interestingly, BMAP-28 peptide had acceptable effect on Carbapenam resistant Enterobacteriaceae including K. pneumoniae, E. coli, C. freundii and E. Cloacae isolates with less toxicity.